Pregabalin and Speech Pathology Treatment for Refractory Chronic Cough with Laryngeal Hypersensitivity

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1072056

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Persistent cough that does not respond to medical treatment is debilitating and frustrating for the sufferer and very expensive for the Australian government. This research will provide a new and effective treatment option and extend our current reputation as the world leader in the identification and treatment of refractory chronic cough. This treatment strategy has not been trialled before and the findings will change current medical practice and significantly reduce community health costs.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2018

Funding Scheme: Early Career Fellowships

Funding Amount: $155,747.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cough | hypersensitivity | laryngeal dysfunction | quality of life | sensory neuropathy

Related Links